Sciex has launched a capillary electrophoresis solution, the BioPhase 8800 system. The multi-capillary system for CE-SDS processes eight samples simultaneously, retaining sample integrity and delivering consistent results.
The development of biopharmaceutical therapies requires the ability to measure and monitor critical quality attributes in short timelines. The BioPhase 8800 system has been designed to enables high throughput, sensitive CE-SDS and CIEF analysis, to result in accuracy for large sample sets. With this system, scientists can quickly understand molecular liabilities and ensure the development and manufacture of robust, stable biologics, says Sciex.
“Customers told us about their challenges transitioning to more innovative biologics where samples are getting numerous and more complex, and results are needed quicker. They are under pressure to close the developability gaps earlier in the development process and need faster analysis with confident results,” said Mani Krishnan, VP GM, CE & Biopharma at Sciex. “Today, we are thrilled to usher in a new phase of biologic drug analysis with the BioPhase 8800 system as we continue our collaborations with biologics manufacturers at the forefront of innovation.”
